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Mutation of Surface Histidines in Haemophilus influenzae
Carbonic Anhydrase to Enable Purification by Metal Affinity
Chromatography
Shelby E. Scola and Dr. Kathleen Cornely
From the Department of Chemistry and Biochemistry, Providence College, Providence, Rhode
Island 02918
H. influenzae carbonic anhydrase (HICA) is a β-carbonic anhydrase that is important
to the survival of the human respiratory tract pathogen H. influenzae. Although HICA
shares a high degree of structural similarity with E. coli carbonic anhydrase (ECCA), HICA
lacks ECCA’s nickel-binding capabilities. However, previous research suggests that the
engineering of histidine clusters on HICA through the mutation of surface residues enables
HICA to gain nickel-binding ability similar to that of ECCA. Here we present the production
and analysis of a K129 L133 HICA double mutant. Using PyMOL to visualize the mutant, it
was determined that the mutated histidines form a cluster of four histidines which are all
located between approximately 3.7 to 6.7 Å from each other. The mutant plasmid was
constructed using site-directed mutagenesis via megaprimer PCR, and then overexpressed
in E. coli to obtain a protein lysate with a protein concentration of 16.23 ± 0.06 mg/mL.
The ability of the mutant HICA protein to bind to nickel was analyzed using Ni-NTA
chromatography, followed by SDS-PAGE analysis of the chromatography fractions. The
results of the SDS-PAGE analysis suggest that the mutant HICA protein bound weakly to the
nickel column, requiring 25 mM imidazole to elute.
Carbonic anhydrases are zinc metalloenzymes that catalyze the reversible
interconversion of CO2 and bicarbonate:
𝐶𝑂2 + 𝐻2 𝑂 ⇌ 𝐻𝐶𝑂3 − + 𝐻 +
Haemophilus influenzae carbonic anhydrase (HICA) is a member of the β-form of carbonic
anhydrases, a class of enzymes found in bacteria, yeast, and plant chloroplasts (1). HICA is
essential for the survival of nontypeable (unencapsulated) strains of H. influenzae bacteria
in ambient air and intracellular survival in host cells. These bacterial strains are one of the
leading causes of noninvasive mucosal infections, such as otitis media, sinusitis, and
conjunctivitis (2). Therefore, HICA could be a potential antibiotic target in the treatment of
these infections. However, the potential to carry out further research on HICA hinges on
the ability to purify it in large quantities.
Purification of HICA and other proteins is commonly achieved by metal affinity
chromatography after a histidine tag has been engineered onto the N-terminus or Cterminus of the polypeptide chain. Some advantages of this method are its ability to purify
proteins in one step and the ease of imidazole elution. However, drawbacks include
potential interference of tags with quaternary structure or the introduction of random
coiling that could interfere with downstream techniques. If the tag is close to the active
site, it could change the conformation of the protein, resulting in proteins that have lost
their function. Sometimes this can be fixed by moving the tag to the opposite terminus, but
this does not always prove effective (1).

Since some E. coli proteins have been discovered that exhibit endogenous nickel
affinity, it is possible that instead of engineering a terminal histidine tag, metal affinity
could be engineered on the surface of a protein. Since four of the six ligand positions on
Ni2+ ions are usually occupied by other ligands, theoretically only two histidines may be
necessary for nickel binding. Based on known inorganic structures, the optimal distance
between these two histidines is expected to be between 4 and 7 Å apart (1). Although
histidine tags are usually engineered with six adjacent histidines at the terminus, proteins
could be engineered to have histidine clusters to mimic those of proteins with endogenous
nickel affinity. A better understanding of the parameters of histidine location on the
surface of proteins required for metal-affinity chromatography would provide a broadly
applicable technique for protein purification and eliminate the need to use histidine tags.
To begin defining these parameters, proteins with endogenous metal affinity must first be
examined.
One such protein that exhibits endogenous metal affinity and is closely related to
HICA is E. coli carbonic anhydrase (ECCA), which has been shown to bind to so tightly to
Ni2+ columns that 250 to 300 mM imidazole is needed to elute it (1). Like other β-carbonic
anhydrases, ECCA’s quaternary structure is a dimer of dimers. The tetramerization
interface between dimers is partially solvent exposed and contains two symmetry-related
clusters of histidines. Each cluster includes six histidines from two chains (His72, His122,
and His160 from one chain; His720, His1220, and His1600 from the other chain). Within
the same chain, the histidines are between 5 and 7 Å apart, while the interchain distances
are closer to 3.5 and 4.5 Å. These side chains could be within the sphere of rotation
necessary to optimize nickel coordination since nickel(II)–histidine coordination distances
have been observed in protein structures at 1.8 to 2.4 Å (1).
Recognizing that HICA, while unable to bind to Ni2+, does share 38% identity,
quaternary structure, and activity profile similar to ECCA, and only partially conserves the
cluster of histidines in the tetramerization interface (His72, His122, and Arg160), Hoffman
explored the possibility of mutating HICA’s Arg160 residue to histidine to recreate ECCA’s
metal affinity. While wildtype HICA does not bind to the nickel column, the Arg160 mutant
was shown to elute with 190 mM imidazole, while ECCA elutes at 278 mM imidazole.
Furthermore they reported that while optimizing Arg160His HICA’s purification to
minimize secondary retention during the binding and wash steps meant that the protein
variant eluted earlier in the gradient, the HICA mutant similarly achieved greater than 90%
purity. In addition, the surface mutations did not influence the overall structure or
function of the HICA protein, since steady-state kinetic activity and oligomerization state
were similar to that of wildtype HICA (1).
Using their work as a model, we wanted to explore the possibility of increasing the
metal affinity of HICA by mutating other solvent-exposed residues besides Arg160. We
chose to engineer a double mutant in which both Lys129 and Leu133 residues were
mutated to histidine, as these residues were present on the surface of the HICA protein and
were located in close proximity (within 4.4 to 6.4 Å) to two other histidines. The goal was
for these four histidines to be close enough to form a cluster to optimize nickel
coordination. Here we report the successful generation of a K129 L133 mutant HICA
protein, and its ability to bind weakly to the nickel columns, requiring 25 mM imidazole to
elute.

EXPERIMENTAL PROCEDURES
Cultures – DH5α E. coli cells transformed with pHICA were obtained as frozen stock
from the Hoffman laboratory. Cells were taken from frozen stock and inoculated in LB
medium containing 1% tryptone, 0.5% yeast extract, 1% NaCl, and 100 μg/mL ampicillin.
Cultures were incubated in a roller drum for 23 hours at 37°C.
Plasmid miniprep – A plasmid miniprep for the pHICA plasmid was performed using
a Zymo Zyppy Plasmid Miniprep Kit from Zymo Research. Kit instructions were followed
with the only exception being that the samples were incubated with Zyppy Elution Buffer
for 20 min instead of 1 min. Plasmid DNA concentrations were determined via NanoDrop
1000 Spectrophotometer (ThermoScientific) to be 95.7 ng/μL.
Site-Directed Mutagenesis (3)– In order to amplify the mutation of interest to
produce a megaprimer, a PCR mixture containing 3.83 ng/μL pHICA plasmid template, 1
pmol/μL forward primer containing mutations (5’-GGTTTCATCACGGTCATCATCTCG-3’), 1
pmol/μL reverse primer Phi2X (5’-AGCTTGCATGCCTGCCTGCAGTTATTATG-3’), 0.2 mM
dNTP mix, Phusion HF Buffer, and 0.05 units/μL Phusion High-Fidelity DNA polymerase
was made. This sample underwent touchdown PCR (4) with the following protocol: one
initial cycle at 95 °C for 2 min; 40 cycles of 95 °C for 30 sec, 65 °C for 30 sec (temperature
lowered 0.5 °C per cycle), and 72 °C for 30 sec; one cycle at 72 °C for 10 min; then hold at 4
°C. The sample was run on a 1% agarose gel containing TAE (0.04 M Tris, 1 mM EDTA, 0.02
M glacial acid). In order to visualize the bands, 0.001 % SYBR Safe DNA gel stain from Life
Technologies was used. Bands were excised and purified using the Zymoclean Gel DNA
Recovery Kit from Zymo Research. Instructions were followed with the exception that
incubation was performed using pre-warmed (48 °C) elution buffer and samples were
incubated for 7 min.
In order to amplify the entire HICA gene containing the mutation, a PCR sample
containing 3.83 ng/μL pHICA template, 1 pmol/μL PhiQC primer (5’CACTGCATAATTCGTGTCGCTCAAGG-3’), a third of the megaprimer sample obtained from
the previous round of PCR, 0.2 mM dNTP mix, Phusion HF Buffer, and 0.05 units/μL
Phusion High-Fidelity DNA polymerase was made. This sample underwent classic PCR,
with an initial cycle at 95°C for 2 min; 30 cycles of 95°C for 30 sec, 55°C for 30 sec, and 72°C
for 1 min; an extension cycle of 72°C for 10 min; and then a final cycle held at 4°C. The
sample was run on a 1% agarose gel containing TAE (0.04 M Tris, 1 mM EDTA, 0.02 M
glacial acid). In order to visualize the bands, 0.001 % SYBR Safe DNA gel stain from Life
Technologies was used. Bands were excised and purified using the Zymoclean Gel DNA
Recovery Kit from Zymo Research. Instructions were followed with the exception that
incubation was performed using pre-warmed (48 °C) elution buffer and samples were
incubated for 10 min.
In order to amplify the entire pHICA plasmid containing the mutation, a PCR sample
containing 3.83 ng/μL pHICA template, a third of the megaprimer sample obtained from
the previous round of PCR, 0.2 mM dNTPs, Phusion HF Buffer, and 0.05 units/μL Phusion
High-Fidelity DNA polymerase. This sample underwent classic PCR, with an initial cycle at
95°C for 2 min; 30 cycles of 95°C for 1 min, 60°C for 1 min, and 72°C for 5 min; an extension
cycle of 72°C for 10 min; and then a final cycle held at 4°C. The sample was run on a 0.8%
agarose gel containing TAE (0.04 M Tris, 1 mM EDTA, 0.02 M glacial acid). In order to
visualize the bands, 0.001% SYBR Safe DNA gel stain from Life Technologies was used.

Transformation of mutant pHICA into E. coli cells – In order to obtain a higher
quantity of mutant pHICA plasmid, the plasmid was transformed into E. coli cells. First,
PCR samples were treated with 10 units of Dpn1 enzyme in order to digest the parent
plasmid DNA. Samples were then incubated for approximately 2.5 hours at 37°C.
Following incubation, 2.5 μL of the Dpn1-treated sample was added to 50 μL of DH5α
competent E. coli cells from Zymo Research Mix and Go E. coli Transformation Kit and
Buffer Set. Following a 30 min incubation on ice, samples were plated on pre-warmed LB +
amp plates (100 μg/mL ampicillin) and incubated overnight at 37°C. A transformant
colony was inoculated in LB + amp medium and incubated overnight at 37°C.
Sequencing – To prepare a sample for sequencing, the liquid culture was centrifuged
and the pellet was resuspended in 1 mL of LB + amp medium. A plasmid miniprep was
then performed on the sample using a Zymo Zyppy Plasmid Miniprep Kit. Kit instructions
were followed with the only exception being that the samples were incubated with prewarmed (48 °C) Zyppy Elution Buffer for 30 min instead of 1 min. Plasmid DNA
concentrations were determined via NanoDrop 1000 Spectrophotometer to be 29.0 ng/μL.
The sample sent for sequencing contained 21.8 ng/μL plasmid DNA, 1.5 μM
PRRXseqforward primer (5’-GGCTCGTATAATGTGTGGAATTG-3’), and TE buffer (10 mM
Tris, 1 mM EDTA) to obtain a total volume of 20 μL. The plasmid sample was shipped to
the MGH Core Facility for sequencing.
Transformation of mutant pHICA plasmid into autolysis cells – In preparation for
transformation, DH5α E. coli cells containing the mutant plasmid were inoculated in 5 mL
LB + amp medium, incubated overnight at 37 °C, and then underwent a plasmid miniprep
using a Zymo Zyppy Plasmid Miniprep Kit. Kit instructions were followed with the only
exception being that the samples were incubated with pre-warmed (48 °C) Zyppy Elution
Buffer for 30 min instead of 1 min. Mutant plasmid DNA concentrations were determined
via NanoDrop 1000 Spectrophotometer to be 75.0 ng/μL. A transformation mixture
containing 3.57 ng/μL mutant plasmid and 50 μL of XJb Autolysis E. coli cells from Zymo
Research was incubated on ice for 15 min, then plated on pre-warmed (37 °C) LB + amp
plates. The plates were incubated overnight at 37 °C.
Production scale overexpression of folded mutant HICA protein – LB + amp liquid
cultures of XJb E. coli transformants with the mutant plasmid were pelleted at 8000 × g for
5 min, then the pellets were resuspended in 10 mL LB + amp medium. These cells were
inoculated in medium containing 900 mL TB nutrient (1.33% w/v tryptone, 2.67% w/v
yeast extract, 0.44% glycerol), 100 mL TB buffer (0.89 M phosphate, pH 8), ampicillin, and
3 mM arabinose, and incubated for approximately 3 hours. Then 0.2 mM IPTG was added
to induce expression of the mutant protein. Cells were incubated overnight with shaking at
37°C. Cells were harvested by centrifugation at 8000 × g for 10 min. The resulting wet cell
pellet weighed 10.488 g. The pellet was frozen and then subsequently thawed to lyse cells.
Cell lysis – Cells were resuspended in ~3 mL extraction buffer (20 mM Tris, 200 mM
NaCl, pH 8) per gram of cell pellet. Half of a Pierce protease inhibitor mini-tablet from
Thermo Scientific was added to the mixture, and the mixture was incubated at 37 °C with
vigorous shaking until homogenous. In order to reduce clumping, 16 units of DNAse I from
New England BioLabs were added to the sample. Following incubation, the mixture was
centrifuged at 35,000 × g for 30 min. The supernatant was then centrifuged for an
additional 15 min at 35,000 × g.

BCA assay – A BCA assay (5) was performed using the Pierce BCA Protein Assay Kit
from Thermo Scientific to determine the protein concentration of the lysate containing
soluble mutant HICA proteins. Kit instructions were followed with the only exception
being that the BSA standards were purchased rather than prepared. The standards used
were a set of BSA standards (concentrations ranging from 125 μg/mL to 2000 μg/mL) from
Thermo Scientific. In addition, the sample of unknown concentration (the lysate of soluble
mutant HICA proteins) was diluted 1/20 so that the concentration would fall within the
range of the standards. Absorbance values at 562nm were obtained using a Cary 50.
Ni-NTA Chromatography (6) – To prepare an equilibrated matrix, 2 mL of Ni-NTA
slurry (1 mL bed volume) from Qiagen was centrifuged at 2500 rpm, the supernatant was
removed, 4 mL of lysis buffer (20 mM Tris, 200 mM NaCl, pH = 8) was added, the mixture
was inverted to mix, centrifuged again at 2500 rpm, and the supernatant was removed. To
this equilibrated matrix, 8 mL of protein lysate (thawed on ice) and 10 mM imidazole were
added, and the mixture was incubated for 60 min with shaking at 4°C. Following
incubation, the lysate-Ni-NTA mixture was loaded into a column and the flow-through (the
first 8 column volumes) was collected. The next 15 column volumes were washed with 25
mM imidazole, then 5 column volumes were washed with 50 mM imidazole, 5 column
volumes were washed with 75 mM imidazole, 5 column volumes were washed with 100
mM imidazole, 4 column volumes were eluted with 250 mM imidazole, 4 column volumes
were eluted with 500 mM imidazole, and finally 3 column volumes were eluted with 2 M
imidazole. These fractions were collected for SDS-PAGE analysis.
SDS-PAGE analysis – For SDS-PAGE analysis of the fractions from the Ni-NTA
chromatography, Laemmli procedure (7) was followed with the exception that a 12.5%
separating gel was prepared containing lower Tris buffer (1.5 M Tris, 0.4% SDS, pH = 8),
12.5% acrylamide/0.33% bis-acrylamide, 0.03% ammonium persulfate, and 0.025%
TEMED (N,N,N’,N’-tetramethylethylenediamine). The stacking gel prepared contained
upper Tris buffer (0.5 M Tris, 0.4% SDS, pH = 8), 3% acrylamide/0.08% bis-acrylamide,
0.03% ammonium persulfate, and 0.1% TEMED. The samples contained Laemmli sample
buffer (0.063 M Tris, 10% glycerol, 2 mM DTT, 2.3% SDS, 1% β-mercaptoethanol, pH = 6.8).
Samples were incubated at 100 °C for 3 min. Then the gel was run for approximately 5
hours with a Tris/glycine reservoir buffer (0.025 M Tris, 0.192 M glycine, 0.1% SDS, pH =
8.3) at 55 mamps for the separating gel and 30 for the stacking gel. Following
electrophoresis, the gel was stained overnight with 0.025% Coomassie Blue R-250 staining
solution containing 40% MeOH and 7% HAc, and subsequently destained with a destaining
solution containing 3% glycerol, 10% HAc, and 40% MeOH. The destaining solution was
changed twice over a 3 day period. The gel was dried in a gel dryer for 2 hours at 80 °C and
then 30 min at room temperature.
RESULTS
PyMOL analysis – Analysis of the HICA protein in PyMOL revealed that residues
K129 and L133 were viable for mutation to His because these residues were both within
4.4 to 6.4 Å of pre-existing His residues (Fig. 1A). If these residues were to be mutated to
His, the estimated distances between the mutated His residues and the pre-existing His
residues would be between 3.7 to 6.7 Å (Fig. 1B), so these residues could potentially form a
His cluster that could bind to the nickel column.

Site-directed mutagenesis – In order to amplify a region of the HICA gene containing
the K129 and L133 mutations, a PCR reaction was performed and the resulting product
was run on a gel to verify the length of the DNA fragment produced. The calculated size of
the expected DNA fragment was 342 bp, and the PCR product appeared between 300 and
400 bp on the DNA gel (Fig. 2A).
Using this PCR product that contained the K129 and L133 mutations as a
megaprimer, another PCR reaction was performed in order to amplify the entire HICA gene
containing the K129 and L133 mutations. The result of this second PCR reaction was run
on gel to verify that PCR produced the expected product. The calculated size of the
expected DNA fragment containing the entire HICA gene was 883 bp, and the PCR product
appeared around 1,000 bp on the DNA gel (Fig. 2B).
Using this PCR product of the entire HICA gene containing the K129 and L133
mutations as a megaprimer, another PCR reaction was performed in order to amplify the
entire pHICA plasmid containing the K129 and L133 mutations. The result of this third
PCR reaction was run on a gel to verify that PCR produced the expected product. The
calculated size of the expected DNA fragment was approximately 5 kb, and while the PCR
sample formed some smeared bands on the gel, there was a band around 6 kb that was
assumed to be the mutant pHICA plasmid (Fig. 2C). Sequencing of this plasmid confirmed
that the K129 and L133 mutations were present.
BCA Assay – As shown in Fig. 3, a standard curve was created by plotting absorbance
at 280nm vs. protein concentration of the BSA standards. From the linear regression
performed on the standard curve, the amount of protein in the cell lysate from the lysed
XJb E. coli cells could be quantified. The concentration of protein in the cell lysate was
determined to be 16.23 ± 0.06 mg/mL. However, this number represents the total protein
concentration, not just the concentration of mutant HICA protein.
Ni-NTA Chromatography and SDS-PAGE analysis – Since the mutant protein has two
extra His residues, it is expected to bind more tightly to a nickel column than the wildtype
HICA protein, which is not retained by nickel columns (1). Ni-NTA chromatography was
therefore carried out in order to assess the mutant HICA protein’s affinity for nickel.
Though the elution profile shows a spike in absorbance at 280nm when 100 mM and 250
mM imidazole solutions were applied to the column (Fig. 4), an SDS-PAGE analysis was
necessary to determine whether or not these fractions contained the mutant HICA protein.
The mutant protein was expected to be about 26 kDa. Bright bands of around size were
present in the SDS-PAGE gel in lanes that contained the cell extract, flow-through, and wash
1, and very faint bands of this size appeared in the other lanes as well (Fig. 5). These faint
bands were deemed insignificant, as most of the protein eluted in the preceding lanes.
Since wash 1 was a 25 mM imidazole wash, it was concluded that the mutant HICA protein
only required up to 25 mM imidazole to elute.

FIGURE 1. Pymol images of mutated amino acids K129 and L133. A, amino acid side
chains before K129 and L133 residues mutated. B, amino acid side chains after residues
mutated to His. Green-colored histidines are pre-existing proximal histidines, cyan-colored
amino acids are the residues of interest for mutation, and yellow dotted lines indicate
distances (in Å) between various residues.

FIGURE 2. Gels for length verification for K129 L133 mutation region, HICA gene, and
pHICA plasmid. A, PCR products from the amplification of the K129 L133 mutation region.
B, PCR products from the amplification of the HICA gene. C, PCR products from the
amplification of the pHICA plasmid.
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FIGURE 3. Standard curve for BCA assay. Points represent data from the BSA standards.
The linear regression equation is Abs = 0.9298(conc.) + 0.1601, with R2 = 0.99183.
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FIGURE 4. Ni-NTA chromatography elution profile. The protein lysate sample
containing the soluble mutant plasmid was passed through a Ni-NTA column (1 column
volume = 1 mL). The first 8 column volumes were flow-through and the following column
volumes were washed with various concentrations of imidazole (see Table 1).

Table 1
Key for Ni-NTA chromatography elution profile (Fig. 4).

FIGURE 5. SDS-PAGE analysis of Ni-NTA chromatography fractions. Fractions from NiNTA chromatography were run on a 12.5% separating SDS-PAGE gel, along with a
BenchMark Pre-Stained Protein Ladder and cell extract from cell lysis (see Table 2 for
contents of each lane).

Table 2
Contents of each lane in SDS-PAGE analysis (Fig. 5).

DISCUSSION
In this study, we successfully generated a mutant HICA protein, in which the K129
and L133 residues were mutated to histidines. These residues were chosen for mutation
because PyMOL analysis confirmed their location on the surface of the HICA protein, their
close proximity (between 4.4 to 6.4 Å) to pre-existing histidine residues on the same chain,
and an estimated proximity of between 3.7 to 6.7 Å to these same histidines following
mutation of K129 and L133 to His (Fig. 1). These distances between histidines were
assumed to be favorable for nickel coordination based on previous research that
demonstrated that distances of 5 to 7 Å between histidines on the same chain in ECCA were
able to bind so strongly to the nickel column that the protein required 250 – 300 mM
imidazole to elute (1). Thus, the mutation of the K129 and L133 residues to His was
predicted to optimize coordination to nickel, since the newly engineered His residues
would be close enough to the pre-existing ones to form a cluster of histidines. As it was
previously demonstrated that mutating HICA’s Arg160 residue to His sufficiently recreated
ECCA’s metal affinity (1), we knew that this method of engineering a histidine cluster was
effective, however, we wanted to explore whether that cluster could be engineering on
other locations on the solvent-exposed surface of HICA. When exploring other areas of the
surface of the protein, the K129 and L133 residues were also chosen based on the fact that
they were far from the zinc-containing active site. Therefore, mutation of this region would
not be predicted to interfere with enzymatic function of the protein.
Although the K129 and L133 mutations were designed to generate a protein with
favorable inter-histidine distances for nickel binding, our data suggest that our K129 L133
mutant HICA protein exhibits weak nickel affinity. From the SDS-PAGE results (Fig. 5), it
appears that most of the mutant HICA protein elutes with only 25 mM imidazole, since the

protein was only present in appreciable quantities in the cell extract, flow-through, and 25
mM imidazole wash, and was present only negligibly in the washes and elutions of higher
imidazole concentration. However, there were no washes performed with concentrations
below 25 mM imidazole, so it is possible that the mutant HICA protein would have eluted
with even lower concentrations of imidazole. This does not come close to recapitulating
the nickel-binding affinity of ECCA, which requires 250 to 300 mM imidazole to elute (1).
Our mutant was also much less effective than the Arg160His mutant, which required 190
mM imidazole (1). One hypothesis as to why our K129 L133 mutant HICA protein did not
exhibit the strong nickel binding predicted could be that the mutations were not actually
made to an area of the protein that was solvent-exposed. Though PyMOL showed the
region on the surface of the protein, it could be that the solvent does not actually penetrate
into that groove in the protein. Another reason could be that although there were four
histidines in the cluster, they were not actually the right distances from each other, or there
were not enough of them to bind to the Ni2+.
Since we were unable to perform tests on the kinetic activity of our mutant HICA
protein, we do not know if the mutation affected enzymatic activity. However, we can infer
from what we know about the HICA mechanism, that our mutation most likely did not
affect the enzymatic activity, as the mutation was not made to the zinc-containing active
site. The fundamental structural unit of HICA is a dimer composed of two identical protein
chains (8). All β-carbonic anhydrases contain one zinc ion per monomer in a pseudotetrahedral coordination environment of the type Cys2His(X), where X is water, an anion or
an Asp residue. HICA is a type II β-carbonic anhydrase, meaning that its active site zinc ion
is coordinated to 4 protein ligands, Cys42, Asp44, His98, and Cys101. HICA also has a
narrow, hydrophobic active site cleft that lies along the dimer interface and leads to the
active site zinc ion. This zinc helps to catalyze the reaction:
𝐶𝑂2 + 𝐻2 𝑂 ⇌ 𝐻𝐶𝑂3 − + 𝐻 +
In the forward reaction, CO2 is concentrated in the active site by association with
hydrophobic residues that line that active site cleft. The CO2 is then positioned for
nucleophilic attack by a zinc-bound hydroxide ion, which is oriented by the Asp residue.
The zinc-bound hydroxide undergoes a nucleophilic addition to CO2, converting it to a
bicarbonate ion. The developing negative charge on the bicarbonate ion is stabilized by Hbonding to a Gln 151’ residue. Then water exchanges for bicarbonate at the zinc ion, and a
proton is lost from the zinc-bound water to regenerate the zinc-bound hydroxide ion.
Understanding this mechanism allowed us to choose mutation sites (K129 and L133) in the
HICA monomer that were located far from the monomer’s zinc active site. However, kinetic
data still needs to be collected to ensure that enzymatic function was in fact undisrupted.
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